Vitals Today
  • Breaking News
  • Health
  • Policy
  • Studies
  • Companies
  • Professionals
  • Español
    • English
    • Español
No Result
View All Results
Vitals Today
  • Breaking News
  • Health
  • Policy
  • Studies
  • Companies
  • Professionals
  • Español
    • English
    • Español
No Result
View All Results
Vitals Today
No Result
View All Results

Companies » Andalusia supports research into the rare disease NEDAMSS with 15,000 euros

Andalusia supports research into the rare disease NEDAMSS with 15,000 euros

Andalusia receives 15,000 euros to research the rare disease NEDAMSS, supporting advances in treatments for this neurodevelopmental disorder.

by Wendy Lazcano
March 17, 2025
Reading time: 2 mins read
A doctor in a white coat and glasses, with a stethoscope around his neck, studying several open books on a desk, showing a concentrated expression, against a bookshelf and a light wall.

Canva

Share on BlueskyShare on TwitterShare on Linkedin
  • Author
  • Recent Posts
Wendy Lazcano
Editor at Vitals Today
She is an experienced journalist who has worked in print media such as Diario de Cuba and Review Energy, as well as hosting radio (Wradio/Grupo PRISA) and television (Canal 33) programs. A specialist in politics and regulations, Wendy stands out for her ability to analyze and explain complex issues.
Latest posts by Wendy Lazcano (see all)
  • What is vortioxetine and what is this antidepressant prescribed for? - October 7, 2025
  • Ketoconazole Shampoo: How to Use It Correctly for Dandruff and Dermatitis? - October 6, 2025
  • What is the best time to take Hydroferol to absorb it better? - October 3, 2025

The association 'For Elenita's smile' has donated 15,000 euros to investigate the rare disease NEDAMSS in Andalusia. This disorder affects only nine people in Spain. The donation is being made to the Progress and Health Foundation, with the aim of promoting research.

NEDAMSS, a complex neurodevelopmental disorder

NEDAMSS is a rare disease caused by a mutation in the IRF2BPL gene. This disorder causes regression, loss of speech, abnormal movements, and epilepsy. The disease progresses rapidly and currently has no cure.

One of those affected is Elenita, a seven-year-old girl from Granada. Despite current therapies, her parents hope that research will provide a definitive treatment.

Research in Andalusia to find new solutions

Researcher Thomas Widmann leads one of the most promising projects at the GENYO Center in Granada. This study has two approaches. The first involves growing cell lines with patient-specific variants as a model of IRF2BPL. These lines are used to test existing drugs that could be useful for the disease.

The second approach seeks to better understand the structure of the IRF2BPL protein. This could lead to the identification of new therapeutic targets. This research is complemented by studies at other centers, such as the Murcian Institute of Biosanitary Research.

Thanks to the collaboration between the patient association, public institutions, and the University of Granada, new hope is emerging for those affected by this rare disease.

Tags: Neurological DiseasesSpainInvestmentFront page
Previous Post

Andalusia invests 4.2 million euros in promoting hematologic cancer treatments

Next Post

Study demonstrates the cost-effectiveness of MRI in the treatment of steatotic liver disease

Related Stories

A doctor in a white coat writes on a sheet of paper while a stethoscope and medication bottles are visible on the table.
Health

What is vortioxetine and what is this antidepressant prescribed for?

October 7, 2025
A woman with brown hair sits, listening attentively to a dark-skinned female doctor in a white coat, who is talking animatedly in front of a table with a laptop, in a modern office with beige walls and a circular mirror on the wall.
Health

Ketoconazole Shampoo: How to Use It Correctly for Dandruff and Dermatitis?

October 6, 2025
A variety of pills and capsules of different colors and shapes, including white, orange, and green tablets, arranged on a clear surface.
Health

What is the best time to take Hydroferol to absorb it better?

October 3, 2025
A man sitting opposite a doctor wearing a white coat and stethoscope in an office with a table, a tablet, and several medication bottles visible. The doctor appears to be explaining something to the patient.
Health

Mupirocin vs. Fucidin: Which is Better for Skin Infections?

September 29, 2025
Load More

Most Shared

  • A person holds a blue injection device in their hands, with an additional cartridge and several disposable needles on a wooden table.

    Ozempic in Spain: How much does it cost and how to get it?

    2 shared
    Share 1 Tweet 1
  • Mounjaro in Spain: When did it arrive and what's its price?

    4 shared
    Share 2 Tweet 1
  • Can I mix Enantyum and Paracetamol if the pain is very severe?

    2 shared
    Share 1 Tweet 1
  • Dexketoprofen vs. Ibuprofen: Which is better for pain?

    1 shared
    Share 0 Tweet 0
  • Can Ozempic be purchased without a prescription at pharmacies in Spain?

    0 shares
    Share 0 Tweet 0

logo for Vitals Today, your trusted source for health news, a green heart with the words Vitals Today, all in green

Vitals Today, your trusted source for healthcare news. Stay updated on the latest studies, regulations, and industry initiatives.

  • LinkedIn
  • X
  • Bluesky
  • About Us
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
  • Contact

© 2024 Vitals Today - all rights reserved

Manage consent

To deliver the best experiences, we use technologies such as cookies to store and/or access device information. Accepting these technologies will allow us to process data such as browsing behavior or unique identifiers on this site. Not accepting or withdrawing consent may negatively impact certain features and functionality.

Functional Always active
Technical storage or access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
Storage or technical access used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
Technical storage or access is necessary to create user profiles for the purpose of sending advertising, or to track the user on a website or across multiple websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
No Result
View All Results
  • Portal
  • Breaking News
  • Policy
  • Studies
  • Companies
  • Professionals
  • Español
    • English
    • Español

© 2024 Vitals Today - all rights reserved